Chemours Co - CC STOCK NEWS

Chemours (NYSE: CC) reported Q4 2024 financial results with net sales of $1.4 billion, in line with the prior year, and a net loss of $8 million ($0.05 per share). The company's Thermal & Specialized Solutions segment achieved record fourth quarter sales, with 23% growth in Opteon™ Refrigerants.

Full year 2024 results showed net sales of $5.8 billion, down 5% from 2023, with net income of $86 million ($0.57 per share). Adjusted EBITDA was $786 million, compared to $1.0 billion in 2023. The company returned $148 million to shareholders through dividends.

For 2025, Chemours projects Adjusted EBITDA between $825 million and $975 million, with capital expenditures ranging from $250 million to $300 million. The company completed its Opteon™ YF expansion at Corpus Christi, Texas, and announced a partnership with PCC Group for a chlor-alkali facility at its DeLisle, Mississippi TiO2 plant.

Chemours (NYSE: CC) has announced its quarterly dividend payment for the first quarter of 2025. The company's Board of Directors has declared a cash dividend of $0.25 per share on common stock. The dividend will be distributed on March 14, 2025, to shareholders who are recorded as stockholders at the close of business on February 28, 2025.

Chemours (NYSE: CC) has announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. Turner brings extensive experience in legal matters, corporate governance, public policy, and global risk management. Her career includes significant roles at Hershey and Coca-Cola, where she served in senior legal positions.

Turner's professional journey includes serving as a Partner at Akin Gump Strauss Hauer & Feld, holding key positions in the U.S. Department of the Interior, and retiring from Hershey as Senior Vice President, General Counsel, and Corporate Secretary. She currently serves on the Board of Directors for FirstEnergy and various non-profit organizations.

The company also announced its 2025 Annual Meeting of Shareholders will be held on April 22, 2025, at 10:00 a.m. EDT, marking a return to its regular annual meeting calendar.

The Chemours Company (NYSE: CC) has announced it will release its fourth quarter 2024 financial results before market opens on Tuesday, February 18, 2025. The company will host a conference call to discuss these results at 8:00 a.m. Eastern Standard Time on the same day.

The conference call will be accessible to the public via webcast through the company's investor relations website. Presentation slides will accompany the discussion, and a replay of the webcast will be made available at investors.chemours.com.

Chemours (NYSE: CC) has announced key leadership changes effective March 3, 2025. Damián Gumpel has been appointed as President of the Titanium Technologies (TT) business segment, bringing extensive chemical industry experience from his previous roles at Olin and Dow Inc. Diane Iuliano Picho, who served as Interim TT Business President, has been appointed Chief Enterprise Enablement Officer.

Gumpel will focus on strengthening the TT business and implementing the TT Transformation Plan while contributing to Chemours' Pathway to Thrive strategy. Picho will lead the new Enterprise Enablement unit, overseeing Procurement and key Centers of Excellence, including Manufacturing, Commercial, and Digital operations.

Additionally, Matthew Abbott, Senior Vice President and Chief Enterprise Transformation Officer, will leave the company on February 3, 2025, after eight years of service.

Chemours (NYSE: CC) has appointed Joseph (Joe) Kava to its Board of Directors, effective January 3, 2025. Kava, currently Vice President of Data Centers at Google, brings three decades of experience in leadership, operational, and technical roles. At Google, he oversees site selection, design, construction management, operations, and sustainability of the company's global data centers.

Prior to Google, Kava served as Chief Operating Officer at RagingWire Enterprise Solutions and spent 17 years in the semiconductor industry with LSI Logic and Applied Materials. He holds a BS in Materials Engineering and four U.S. patents in reactive ion and plasma etch technology.

The appointment aligns with Chemours' Pathway to Thrive business strategy, particularly in advancing their growth in AI and high-performance computing applications, specifically in data center cooling solutions.

The Chemours Company (NYSE: CC) has successfully completed the repricing of its Tranche B-3 Euro denominated Term Loan, which is due in August 2028. The Second Amendment reduces the applicable margin on the company's €415,000,000 Euro denominated term loan facility from adjusted EURIBOR + 4.00% to adjusted EURIBOR + 3.25%. The maturity date and other terms of the Term B-3 Euro Term Loan Facility remain substantially unchanged.

Chemours (NYSE: CC) announced that PCC Group plans to construct and operate a chlor-alkali facility at Chemours' titanium dioxide plant in DeLisle, Mississippi. The companies have entered into a chlorine supply agreement, pending customary conditions. The new facility will have an annual capacity of 340,000 metric tons and utilize state-of-the-art technology for maximum energy efficiency.

Construction is scheduled to begin in early 2026, with operations starting in 2028. The project requires no upfront financial commitment from Chemours and aims to lower manufacturing costs while improving supply reliability. The facility will produce caustic soda as a co-product, which PCC will sell to strategic partners and on the open market. The project is expected to create up to 1,200 temporary construction jobs and permanent positions for skilled personnel.

The Chemours Company (NYSE: CC) has successfully completed the repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan, which is due in August 2028. The repricing reduces the applicable margin on the company's $1.07 billion senior secured term loan facility from adjusted Term SOFR + 3.50% to adjusted Term SOFR + 3.00%, or from adjusted base rate plus 2.50% to adjusted base rate plus 2.00%. The maturity date and other terms remain substantially unchanged.